Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry

被引:55
作者
Kushitani, Kei [1 ]
Takeshima, Yukio [1 ]
Amatya, Vishwa Jeet [1 ]
Furonaka, Osamu [1 ]
Sakatani, Akio [1 ]
Inai, Kouki [1 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Pathol, Minami Ku, Hiroshima 7348551, Japan
关键词
CAM5.2; immunohistochemistry; sarcomatoid carcinoma; sarcomatoid mesothelioma; true sarcoma;
D O I
10.1111/j.1440-1827.2007.02193.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Differentiation of sarcomatoid mesothelioma from other sarcomatoid tumors involving the pleura and other structures by light microscopy remains an important diagnostic challenge for surgical pathologists. The purpose of the present study was to investigate the utility of diagnostic immunohistochemistry for differentiating sarcomatoid mesothelioma from its histological mimics: true sarcoma and pulmonary sarcomatoid carcinoma. A total of 39 specimens of mesotheliomas with sarcomatoid components, 43 specimens of true sarcomas, and nine specimens of pulmonary sarcomatoid carcinomas were obtained from Japanese patients and examined using a 10-antibody panel (calretinin, WT1, AE1/AE3, CAM5.2, epithelial membrane antigen, desmin, alpha-smooth muscle actin, S-100 protein, CD34, and CD68). CAM5.2 had the highest sensitivity and specificity for differentiating sarcomatoid mesothelioma from true sarcoma. The combination of CAM5.2, WT1, and AE1/AE3 is recommended for routine pathological diagnosis. Accurate clinical information is necessary for differentiating sarcomatoid mesothelioma from sarcomatoid carcinoma.
引用
收藏
页码:75 / 83
页数:9
相关论文
共 32 条
[1]  
[Anonymous], 2006, ATLAS TUMOR PATHOL
[2]  
Argani P, 1998, MODERN PATHOL, V11, P65
[3]   The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2 [J].
Attanoos, RL ;
Griffin, A ;
Gibbs, AR .
HISTOPATHOLOGY, 2003, 43 (03) :231-238
[4]   Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms [J].
Attanoos, RL ;
Dojcinov, SD ;
Webb, R ;
Gibbs, AR .
HISTOPATHOLOGY, 2000, 37 (03) :224-231
[5]   Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum - Ant bodies to estrogen and progesterone receptors are useful [J].
Barnetson, RJ ;
Burnett, RA ;
Downie, I ;
Harper, CM ;
Roberts, F .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 125 (01) :67-76
[6]   Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma - A study with logistic regression analysis [J].
Carella, R ;
Deleonardi, G ;
D'Errico, A ;
Salerno, A ;
Egarter-Vigl, E ;
Seebacher, C ;
Donazzan, G ;
Grigioni, WF .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (01) :43-50
[7]   3 TYPES OF SPINDLE CELL TUMORS OF THE PLEURA - FIBROMA, SARCOMA, AND SARCOMATOID MESOTHELIOMA [J].
CARTER, D ;
OTIS, CN .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1988, 12 (10) :747-753
[8]   Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma [J].
Chu, AY ;
Litzky, LA ;
Pasha, TL ;
Acs, G ;
Zhang, PJ .
MODERN PATHOLOGY, 2005, 18 (01) :105-110
[9]   Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura [J].
Cury, PM ;
Butcher, DN ;
Fisher, C ;
Corrin, B ;
Nicholson, AG .
MODERN PATHOLOGY, 2000, 13 (02) :107-112
[10]   IDENTIFICATION OF 2 ALTERNATIVE FUSION GENES, SYT-SSX1 AND SYT-SSX2, IN T(X-18)(P11.2-Q11.2)-POSITIVE SYNOVIAL SARCOMAS [J].
DELEEUW, B ;
BALEMANS, M ;
WEGHUIS, DO ;
VANKESSEL, AG .
HUMAN MOLECULAR GENETICS, 1995, 4 (06) :1097-1099